These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17254547)

  • 1. The role of lipid II in membrane binding of and pore formation by nisin analyzed by two combined biosensor techniques.
    Christ K; Wiedemann I; Bakowsky U; Sahl HG; Bendas G
    Biochim Biophys Acta; 2007 Mar; 1768(3):694-704. PubMed ID: 17254547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assembly and stability of nisin-lipid II pores.
    Hasper HE; de Kruijff B; Breukink E
    Biochemistry; 2004 Sep; 43(36):11567-75. PubMed ID: 15350143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity.
    Wiedemann I; Breukink E; van Kraaij C; Kuipers OP; Bierbaum G; de Kruijff B; Sahl HG
    J Biol Chem; 2001 Jan; 276(3):1772-9. PubMed ID: 11038353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the targeted membrane pore formation mechanism by solution NMR: the nisin Z and lipid II interaction in SDS micelles.
    Hsu ST; Breukink E; de Kruijff B; Kaptein R; Bonvin AM; van Nuland NA
    Biochemistry; 2002 Jun; 41(24):7670-6. PubMed ID: 12056898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Insights into Nisin's Antibacterial Mechanism Revealed by Binding Studies with Synthetic Lipid II Analogues.
    't Hart P; Oppedijk SF; Breukink E; Martin NI
    Biochemistry; 2016 Jan; 55(1):232-7. PubMed ID: 26653142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggregates of nisin with various bactoprenol-containing cell wall precursors differ in size and membrane permeation capacity.
    Scherer K; Wiedemann I; Ciobanasu C; Sahl HG; Kubitscheck U
    Biochim Biophys Acta; 2013 Nov; 1828(11):2628-36. PubMed ID: 23872123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
    Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
    Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of the antimicrobial mechanism of mutacin 1140.
    Smith L; Hasper H; Breukink E; Novak J; Cerkasov J; Hillman JD; Wilson-Stanford S; Orugunty RS
    Biochemistry; 2008 Mar; 47(10):3308-14. PubMed ID: 18266322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid II induces a transmembrane orientation of the pore-forming peptide lantibiotic nisin.
    van Heusden HE; de Kruijff B; Breukink E
    Biochemistry; 2002 Oct; 41(40):12171-8. PubMed ID: 12356318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane lipids determine the antibiotic activity of the lantibiotic gallidermin.
    Christ K; Al-Kaddah S; Wiedemann I; Rattay B; Sahl HG; Bendas G
    J Membr Biol; 2008; 226(1-3):9-16. PubMed ID: 19009315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental and dynamic effects explain how nisin captures membrane-bound lipid II.
    Panina I; Krylov N; Nolde D; Efremov R; Chugunov A
    Sci Rep; 2020 Jun; 10(1):8821. PubMed ID: 32483218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lipid II and membrane thickness in the mechanism of action of the lantibiotic bovicin HC5.
    Paiva AD; Breukink E; Mantovani HC
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5284-93. PubMed ID: 21876041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The orientation of nisin in membranes.
    Breukink E; van Kraaij C; van Dalen A; Demel RA; Siezen RJ; de Kruijff B; Kuipers OP
    Biochemistry; 1998 Jun; 37(22):8153-62. PubMed ID: 9609711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane.
    Breukink E; van Kraaij C; Demel RA; Siezen RJ; Kuipers OP; de Kruijff B
    Biochemistry; 1997 Jun; 36(23):6968-76. PubMed ID: 9188693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.
    Wiedemann I; Böttiger T; Bonelli RR; Schneider T; Sahl HG; Martínez B
    Appl Environ Microbiol; 2006 Apr; 72(4):2809-14. PubMed ID: 16597986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin.
    Gut IM; Blanke SR; van der Donk WA
    ACS Chem Biol; 2011 Jul; 6(7):744-52. PubMed ID: 21517116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of bicyclic alkene-/alkane-bridged nisin mimics by ring-closing metathesis and their biochemical evaluation as lipid II binders: toward the design of potential novel antibiotics.
    Ghalit N; Reichwein JF; Hilbers HW; Breukink E; Rijkers DT; Liskamp RM
    Chembiochem; 2007 Sep; 8(13):1540-54. PubMed ID: 17674393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo cluster formation of nisin and lipid II is correlated with membrane depolarization.
    Tol MB; Morales Angeles D; Scheffers DJ
    Antimicrob Agents Chemother; 2015; 59(6):3683-6. PubMed ID: 25870072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semisynthetic Lipopeptides Derived from Nisin Display Antibacterial Activity and Lipid II Binding on Par with That of the Parent Compound.
    Koopmans T; Wood TM; 't Hart P; Kleijn LH; Hendrickx AP; Willems RJ; Breukink E; Martin NI
    J Am Chem Soc; 2015 Jul; 137(29):9382-9. PubMed ID: 26122963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking and molecular dynamics simulations of the ternary complex nisin2:lipid II.
    Mulholland S; Turpin ER; Bonev BB; Hirst JD
    Sci Rep; 2016 Feb; 6():21185. PubMed ID: 26888784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.